,date,symbol,reportedCurrency,fillingDate,acceptedDate,period,revenue,costOfRevenue,grossProfit,grossProfitRatio,researchAndDevelopmentExpenses,generalAndAdministrativeExpenses,sellingAndMarketingExpenses,otherExpenses,operatingExpenses,costAndExpenses,interestExpense,depreciationAndAmortization,ebitda,ebitdaratio,operatingIncome,operatingIncomeRatio,totalOtherIncomeExpensesNet,incomeBeforeTax,incomeBeforeTaxRatio,incomeTaxExpense,netIncome,netIncomeRatio,eps,epsdiluted,weightedAverageShsOut,weightedAverageShsOutDil,link,finalLink,timestamp,est_time,est_date
0,2020-12-31,INMB,USD,2021-03-04,2021-03-04 16:15:56,FY,10916.0,0.0,-10916.0,1.0,5917495.0,6321097.0,0.0,128517.0,12238592.0,12238592.0,0.0,0.0,-12227676,-1120.1608647856358,-12227676.0,-1120.1608647856358,128517.0,-12099159.0,-1108.3875961890803,0.0,-12099159.0,-1108.3875961890803,-1.1778041304081395,-1.1778041304081395,12926539,12926539,https://www.sec.gov/Archives/edgar/data/1711754/000121390021013456/0001213900-21-013456-index.htm,https://www.sec.gov/Archives/edgar/data/1711754/000121390021013456/f10k2020_inmunebioinc.htm,1620593634,16:53:54,20210509
1,2019-12-31,INMB,USD,2020-03-11 00:00:00,2020-03-10 20:28:23,FY,0.0,0.0,0.0,0.0,3281945.0,6016056.0,0.0,0.0,9298001.0,9298001.0,0.0,0.0,-10840001,0.0,-9298001.0,0.0,1542000.0,-7678313.0,0.0,0.0,-7678313.0,0.0,-0.75,-0.75,10272641,10272641,https://www.sec.gov/Archives/edgar/data/1711754/000121390020005916/0001213900-20-005916-index.html,https://www.sec.gov/Archives/edgar/data/1711754/000121390020005916/f10k2019_inmunebioinc.htm,1620593634,16:53:54,20210509
